| Entry |
|
| Name |
Benzodiazepine family |
| Class |
|
| Pathway map |

|
| Compound |
| D00283 | Clozapine (JAN/USP/INN) |
| D00293 | Diazepam (JP19/USP/INN) |
| D00454 | Olanzapine (JAN/USP/INN) |
| D02712 | Tibezonium iodide (INN) |
|
| Reference |
|
| Authors |
David AW, Thomas LL, William OF. |
| Title |
Foye's Principles of Medicinal Chemistry (5th ed) |
| Journal |
Lippincott Williams & Wilkins (2002) |
| Reference |
|
| Authors |
Herranz R. |
| Title |
Cholecystokinin antagonists: pharmacological and therapeutic potential. |
| Journal |
|
| Reference |
|
| Authors |
Zappala M, Grasso S, Micale N, Polimeni S, De Micheli C. |
| Title |
Synthesis and structure-activity relationships of 2,3-benzodiazepines as AMPA receptor antagonists. |
| Journal |
|
| Reference |
|
| Authors |
Solyom S, Tarnawa I. |
| Title |
Non-competitive AMPA antagonists of 2,3-benzodiazepine type. |
| Journal |
|
| Reference |
|
| Authors |
Patchett AA. |
| Title |
2002 Alfred Burger Award Address in Medicinal Chemistry. Natural products and design: interrelated approaches in drug discovery. |
| Journal |
|
Related pathway |
| map07213 | Dopamine receptor agonists/antagonists |
|